YOLFTbeta
Ardelyx Inc

Ardelyx Inc

ARDX · NASDAQ · Healthcare / Biotechnology

3.09USD-0.03 (-0.96%)

Price History

Full chart

Market Stats

Previous Close3.12
Open3.14
Day Range3.05 – 3.15
52-Week Range3.33 – 8.40
Volume2.38M
Market Cap890.75M
P/E (TTM)0.00
Forward P/E9.93
EPS-0.23
Dividend Yield0.00%
Beta0.69
50-Day Avg4.16
200-Day Avg5.71

About

Ardelyx, Inc. discovers, develops, and commercializes medicines to treat unmet medical needs in the United States and internationally. The company offers IBSRELA, a minimally absorbed small molecule therapy for the treatment of patients with irritable bowel syndrome with constipation; and XPHOZAH, a phosphate absorption inhibitor to reduce serum phosphorus in adults with chronic kidney disease on dialysis. Ardelyx, Inc. was formerly known as Nteryx, Inc. and changed its name to Ardelyx, Inc. in June 2008. The company was incorporated in 2007 and is headquartered in Waltham, Massachusetts.

Company Details

  • SectorHealthcare
  • IndustryBiotechnology
  • CEOMr. Michael G. Raab
  • Employees489
  • Headquarters400 Fifth Avenue, Waltham, MA, United States, 02451, USA
  • Websitehttps://www.ardelyx.com

Leadership

  • Mr. Michael G. RaabPresident, CEO & Director · b. 1965
  • Ms. Sue HohenleitnerChief Financial Officer · b. 1971
  • Dr. John Bishop Ph.D.Chief Technical & Quality Officer · b. 1962
  • Mr. Joseph ReillySenior VP of Finance & Principal Accounting Officer · b. 1974
  • Ms. Lisa M. CaperelliSenior Vice President of Investor Relations and Corporate Communications
  • Ms. Felecia W. EttenbergChief Legal Officer · b. 1971
  • Mr. James P. BradyChief Human Resources Officer · b. 1971
  • Mr. Mike KelliherChief Business Officer · b. 1977
  • Dr. Rajani Dinavahi M.D.Chief Medical Officer · b. 1976

Financials

Income Statement

Currency: USD2012-12-312013-12-312014-12-312015-12-312016-12-312017-12-312018-12-312019-12-312020-12-312021-12-312022-12-312023-12-312024-12-312025-12-31
Total Revenue5.41M28.93M31.62M24.03M24.03M42.00M2.61M5.28M7.57M10.10M52.16M124.46M333.62M407.32M
Growth (%)-+434.71%+9.32%-24.02%0.00%+74.81%-93.79%+102.57%+43.36%+33.36%+416.57%+138.61%+168.06%+22.09%
Cost of Revenue1.91M28.09M32.88M1.33M1.29M8.40M466.00K600.00K145.00K1.00M4.12M17.80M50.56M42.60M
Gross Profit3.50M835.00K31.62M24.03M22.73M33.60M2.14M4.68M7.43M9.10M48.04M106.66M283.06M364.72M
Gross Margin64.66%2.89%100.00%100.00%94.61%80.00%82.13%88.64%98.08%90.10%92.11%85.70%84.85%89.54%
Operating Expense12.30M3.70M33.19M53.41M135.63M98.72M93.09M95.94M98.21M163.44M111.80M169.94M311.01M405.70M
Operating Income-8.80M-2.87M-1.56M-29.39M-112.89M-65.11M-90.95M-91.26M-90.78M-154.35M-63.76M-63.28M-27.95M-40.98M
Operating Margin-162.75%-9.90%-4.95%-122.32%-469.89%-155.04%-3488.57%-1728.14%-1199.05%-1528.63%-122.24%-50.84%-8.38%-10.06%
EBITDA-8.13M-2.27M-1.26M-28.56M-111.60M-62.48M-85.08M-84.57M-85.24M-150.85M-60.98M-55.35M-16.71M-29.17M
EBITDA Margin-150.28%-7.86%-3.99%-118.87%-464.50%-148.75%-3263.60%-1601.42%-1125.89%-1494.03%-116.92%-44.48%-5.01%-7.16%
Net Income-9.79M-6.56M-3.21M-29.62M-112.39M-64.34M-91.30M-94.94M-94.31M-158.16M-67.21M-66.07M-39.14M-61.60M
Net Income Margin-180.87%-22.69%-10.16%-123.29%-467.77%-153.19%-3502.03%-1797.77%-1245.71%-1566.46%-128.85%-53.08%-11.73%-15.12%
R&D10.18M28.09M25.90M39.88M94.16M75.48M69.37M71.68M65.05M91.14M35.20M35.54M52.32M68.47M
R&D as % of Total Revenue188.24%97.11%81.90%166.01%391.91%179.72%2661.03%1357.26%859.24%902.64%67.49%28.55%15.68%16.81%
Interest Expense0000003.53M5.73M5.10M4.50M5.07M8.87M20.09M28.40M
Interest Expense % of Total Revenue0.00%0.00%0.00%0.00%0.00%0.00%135.56%108.43%67.35%44.59%9.73%7.13%6.02%6.97%

Balance Sheet

Currency: USD2012-12-312013-12-312014-12-312015-12-312016-12-312017-12-312018-12-312019-12-312020-12-312021-12-312022-12-312023-12-312024-12-312025-12-31
Total Assets37.88M42.90M113.41M116.95M213.13M157.90M183.33M259.78M201.56M149.91M190.07M297.58M435.75M501.60M
Total Liabilities39.12M50.23M52.73M8.04M19.98M18.59M67.52M73.13M75.45M67.30M91.74M130.76M262.46M334.65M
Total Equity-1.24M-7.32M60.68M108.90M193.15M139.31M115.81M186.66M126.11M82.62M98.33M166.82M173.29M166.95M
Cash32.90M34.44M107.29M107.00M74.60M75.38M78.77M181.13M91.03M72.43M96.14M21.47M64.93M68.00M
Total Debt------49.79M57.31M55.44M45.50M36.46M55.98M153.44M211.59M
Net Debt-32.90M-34.44M-107.29M-107.00M-74.60M-75.38M-29.56M-123.83M-35.60M-26.92M-59.68M34.51M88.51M143.60M

Cash Flow

Currency: USD2012-12-312013-12-312014-12-312015-12-312016-12-312017-12-312018-12-312019-12-312020-12-312021-12-312022-12-312023-12-312024-12-312025-12-31
Operating Cash Flow21.98M1.81M13.40M-71.84M-92.53M-65.19M-70.27M-76.48M-81.44M-152.55M-70.04M-89.72M-44.81M-42.48M
Investing Cash Flow-128.00K-278.00K-1.86M-3.45M-131.08M65.29M-29.89M23.37M-31.44M50.95M18.41M-131.25M-18.32M-8.96M
Financing Cash Flow270.00K-1.00K61.31M75.01M191.20M685.00K103.55M155.48M22.78M83.00M75.34M146.29M106.59M54.51M
Capital Expenditure128.00K278.00K1.86M3.45M4.87M2.35M311.00K325.00K324.00K1.87M55.00K344.00K1.01M1.49M
Free Cash Flow21.85M1.53M11.54M-75.29M-97.40M-67.55M-70.58M-76.81M-81.76M-154.42M-70.10M-90.06M-45.82M-43.98M
Dividends Paid--0000---106.00K-25.89M--
FCF to OCF99.42%84.65%86.15%104.81%105.26%103.61%100.44%100.42%100.40%101.22%100.08%100.38%102.26%103.51%
Dividend Paid to FCF--0.00%0.00%0.00%0.00%----0.07%--28.74%--

Earnings

Report DateAug 7, 2014Nov 6, 2014Feb 25, 2015May 12, 2015Aug 12, 2015Nov 12, 2015Mar 4, 2016May 9, 2016Aug 8, 2016Nov 7, 2016Feb 17, 2017May 5, 2017Aug 9, 2017Nov 7, 2017Mar 14, 2018May 8, 2018Aug 7, 2018Nov 7, 2018Mar 6, 2019May 7, 2019Aug 9, 2019Nov 6, 2019Mar 6, 2020May 7, 2020Aug 6, 2020Nov 5, 2020Mar 8, 2021May 6, 2021Aug 13, 2021Nov 12, 2021Feb 28, 2022May 5, 2022Aug 4, 2022Nov 3, 2022Mar 2, 2023May 3, 2023Aug 2, 2023Oct 31, 2023Feb 22, 2024May 2, 2024Aug 1, 2024Oct 31, 2024Feb 20, 2025May 1, 2025Aug 4, 2025Oct 30, 2025Mar 11, 2026Apr 30, 2026Aug 6, 2026Oct 29, 2026
EPS Estimate-0.060.150.02-0.080.11-0.53-0.80-0.66-0.74-0.75-0.72-0.67-0.65-0.54-0.41-0.46-0.44-0.43-0.41-0.39-0.38-0.37-0.33-0.25-0.25-0.30-0.26-0.34-0.37-0.35-0.30-0.23-0.20-0.17-0.02-0.10-0.11-0.11-0.09-0.16-0.11-0.05-0.00-0.07-0.14-0.07-0.02-0.14-0.05-0.03
EPS Actual-0.19-0.21-0.21-0.190.42-0.70-0.65-0.70-0.83-0.65-0.66-0.59-0.54-0.440.21-0.36-0.42-0.39-0.45-0.42-0.41-0.37-0.27-0.25-0.28-0.20-0.32-0.34-0.45-0.42-0.31-0.21-0.19-0.140.06-0.13-0.080.03-0.12-0.11-0.07-0.000.02-0.17-0.08-0.00-0.00-0.15-0.07-
Surprise-216.67%-240.00%-1150.00%-137.50%281.82%-32.08%18.75%-6.06%-12.16%13.33%8.33%11.94%16.92%18.52%151.22%21.74%4.55%9.30%-9.76%-7.69%-7.89%0.00%18.18%0.00%-12.00%33.33%-23.08%0.00%-21.62%-20.00%-3.33%8.70%5.00%17.65%400.00%-30.00%27.27%127.27%-33.33%31.25%36.36%93.20%2957.14%-142.86%42.86%94.29%91.37%-7.14%-40.00%-
TimingPre-marketPre-marketAfter-hoursAfter-hoursPre-marketPre-marketPre-marketAfter-hoursAfter-hoursAfter-hoursAfter-hoursPre-marketPre-marketPre-marketAfter-hoursAfter-hoursAfter-hoursAfter-hoursAfter-hoursAfter-hoursPre-marketAfter-hoursAfter-hoursAfter-hoursAfter-hoursPre-marketPre-marketPre-marketPre-marketPre-marketAfter-hoursAfter-hoursAfter-hoursAfter-hoursAfter-hoursAfter-hoursPre-marketPre-marketAfter-hoursAfter-hoursAfter-hoursAfter-hoursPre-marketAfter-hoursAfter-hoursAfter-hours-After-hoursAfter-hoursAfter-hours

Key Statistics & Ratios

Market Cap890.75M
Enterprise Value871.56M
Trailing P/E0.00
Forward P/E9.93
PEG Ratio-0.08
Price / Sales1.98
Price / Book6.02
EPS-0.23
Book Value0.598
Revenue (TTM)450.89M
Gross Profit (TTM)338.28M
EBITDA-32.11M
Profit Margin-12.35%
Operating Margin-10.28%
Return on Equity-38.61%
Return on Assets-4.25%
Shares Outstanding258.19M
Shares Float210.66M
Beta0.69
Dividend Yield0.00%
Dividend Rate0.00
Payout Ratio0.00%

Analyst Ratings

Strong Buy
Based on 11 analystsTarget 12.90
  • Strong Buy
    8
  • Buy
    2
  • Hold
    1

Ownership Breakdown

Institutions
73.22%
Insiders
3.17%
Retail / Other
23.61%

Top Institutional Holders

  • BlackRock Inc
    21.16M8.20%
  • Millennium Management LLC
    13.90M5.38%
  • State Street Corp
    13.60M5.27%
  • Vanguard Capital Management, LLC
    10.37M4.01%
  • HHG PLC
    8.37M3.24%
  • Delaware Management Holdings Inc
    8.17M3.16%
  • Vanguard Portfolio Management, LLC
    6.66M2.58%
  • Geode Capital Management, LLC
    6.01M2.33%
  • Nuveen, LLC
    5.23M2.03%
  • Two Sigma Investments LLC
    5.21M2.02%
  • The Goldman Sachs Group Inc
    3.22M1.25%
  • AIGH Capital Management, LLC
    3.20M1.24%
  • J. Goldman & Co LP
    3.00M1.16%
  • Point72 Asset Management, L.P.
    2.98M1.16%

Top Fund Holders

  • State Street® SPDR® S&P® Biotech ETF
    7.83M3.03%
  • Nomura Small Cap Core I
    7.63M2.96%
  • Vanguard MStar Total Stk Mkt Idx Invest
    7.40M2.87%
  • iShares Russell 2000 ETF
    6.27M2.43%
  • Vanguard Strategic Equity Inv
    2.70M1.04%
  • Fidelity Small Cap Index
    2.65M1.03%

Stock Splits

  • Jul 20, 20214:1